Funding Clinical Trials

Funding Clinical Trials

Our Agency funds clinical trials testing promising stem cell-based treatments for challenging disease indications to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.
ClinicalDashboardGraphic_APR2018.png

CIRM Clinical Dashboard

Disease Areassort descending Investigator Organization Phase Trial Status Targeted Enrollment Detail
Mark Humayun University of Southern California Phase 1 Active, not recruiting 16
  • Alpha Thalassemia Major
Tippi MacKenzie University of California, San Francisco Phase 1 Recruiting 10
Ralph Kern BrainStorm Cell Therapeutics Phase 3 Recruiting 200
Clive Svendsen Cedars-Sinai Medical Center Phase 1/2 Recruiting 18
Thomas Kipps University of California, San Diego Phase 1/2 Recruiting 156
Crystal Mackall Stanford University Phase 1 Recruiting 57
  • Beta Thalassemia
Ed Conner Sangamo BioSciences, Inc. Phase 1/2 Recruiting 6
Paul Finnegan Angiocrine Bioscience, Inc. Phase 1 Launching N/A
Michael Pulsipher Children's Hospital of Los Angeles Phase 1/2 Launching N/A
Thomas Kipps University of California, San Diego Phase 1 Active, not recruiting 29
Irving Weissman Stanford University Phase 1 Active, not recruiting 88
Christine Brown City of Hope, Beckman Research Institute Phase 1 Recruiting 92
Anthony Gringeri ImmunoCellular Therapeutics Phase 3 Suspended 414
Mark Chao Forty Seven Inc. Phase 1/2 Recruiting 112
Deborah Ascheim Capricor, Inc Phase 2 Completed 25
Rachel Smith Capricor, Inc Phase 2 Active, not recruiting 134
Mehrdad Abedi University of California, Davis Phase 1/2 Recruiting 18
Geoff Symonds Calimmune, Inc. Phase 1/2 Completed 12
John Zaia City of Hope, Beckman Research Institute Phase 1 Recruiting 12
Vicki Wheelock University of California, Davis Phase 1/2 Completed 29
Jeffrey Lawson Humacyte, Inc. Phase 3 Active, not recruiting 355
Samuel Strober Stanford University Phase 1 Active, not recruiting 15
Jeffrey Lawson Humacyte, Inc. Phase 3 Recruiting 240
Steven Deitcher Medeor Therapeutics, Inc. Phase 3 Recruiting 75
  • Leukemia, Acute Myeloid (AML)
Colleen Delaney Nohla Therapeutics Inc Phase 2 Recruiting 220
  • Leukemia, Acute Myeloid (AML)
Mark Chao Forty Seven Inc. Phase 1 Recruiting 96
Steven Dubinett University of California, Los Angeles Phase 1 Launching N/A
Antoni Ribas University of California, Los Angeles Phase 1 Recruiting 12
Robert Dillman Caladrius Biosciences Phase 3 Terminated 250
  • Multiple Myeloma
Matthew Spear Poseida Therapeutics, Inc. Phase 1 Recruiting 40
Kristen Johnson California Institute for Biomedical Research Phase 1 Recruiting 60
Nancy Lane University of California, Davis Phase 1/2 Recruiting 50
  • Pulmonary Hypertension
Michael Lewis Cedars-Sinai Medical Center Phase 1/2 Recruiting 26
Henry Klassen University of California, Irvine Phase 1/2 Completed 28
Henry Klassen jCyte, Inc Phase 2 Active, not recruiting 84
Donald Kohn University of California, Los Angeles Phase 2 Active, not recruiting 10
  • Severe Combined Immunodeficiency, Artemis deficient (ART-SCID)
Morton Cowan University of California, San Francisco Phase 1 Launching N/A
Brian Sorrentino St. Jude Children's Research Hospital Phase 1/2 Recruiting 28
Judith Shizuru Stanford University Phase 1/2 Recruiting 90
Joseph Rosenthal City of Hope, Beckman Research Institute Phase 1 Recruiting 6
Donald Kohn University of California, Los Angeles Phase 1 Recruiting 6
Dennis Slamon University of California, Los Angeles Phase 1 Recruiting 48
Jane Lebkowski Geron Corporation Phase 1 Completed 5
Edward Wirth Asterias Biotherapeutics Phase 1/2 Active, not recruiting 35
Damien Bates SanBio, Inc. Phase 2 Active, not recruiting 156
Howard Foyt ViaCyte, Inc. Phase 1/2 Active, not recruiting 65
Howard Foyt ViaCyte, Inc. Phase 1/2 Recruiting 55
Douglas Losordo Caladrius Biosciences Phase 2 Active, not recruiting 113
  • X-linked Chronic Granulomatous Disease
Donald Kohn University of California, Los Angeles Phase 1/2 Recruiting 10